Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIBER bB-ECHO Esmolol Echocardiography Study
2024-514880-25-00Phase 3Authorised
- Sponsor
- Centro de Investigación Biomédica en Red
- Start
- Jun 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind, single-arm trial of esmolol, sponsored by Centro de Investigación Biomédica en Red. Planned start Jun 2024; status: authorised.
02
Drugs
esmolol
Beyond the preview
Go deeper on 2024-514880-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514880-25-00.